BNP Paribas Financial Markets’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $993K | Buy |
878,987
+7,390
| +0.8% | +$8.35K | ﹤0.01% | 2207 |
|
2025
Q1 | $1.27M | Buy |
871,597
+21,939
| +3% | +$32K | ﹤0.01% | 1891 |
|
2024
Q4 | $1.81M | Buy |
849,658
+803,284
| +1,732% | +$1.71M | ﹤0.01% | 1729 |
|
2024
Q3 | $130K | Buy |
46,374
+39,145
| +541% | +$110K | ﹤0.01% | 2673 |
|
2024
Q2 | $16.8K | Sell |
7,229
-52,591
| -88% | -$123K | ﹤0.01% | 2978 |
|
2024
Q1 | $267K | Sell |
59,820
-63,698
| -52% | -$285K | ﹤0.01% | 2494 |
|
2023
Q4 | $396K | Sell |
123,518
-446,437
| -78% | -$1.43M | ﹤0.01% | 2241 |
|
2023
Q3 | $1.81M | Buy |
569,955
+332,660
| +140% | +$1.05M | ﹤0.01% | 1412 |
|
2023
Q2 | $1.18M | Sell |
237,295
-27,340
| -10% | -$136K | ﹤0.01% | 1558 |
|
2023
Q1 | $1.31M | Buy |
264,635
+17,847
| +7% | +$88.2K | ﹤0.01% | 1608 |
|
2022
Q4 | $1.55M | Sell |
246,788
-41,602
| -14% | -$262K | ﹤0.01% | 1363 |
|
2022
Q3 | $3.11M | Buy |
288,390
+256,934
| +817% | +$2.77M | 0.01% | 1166 |
|
2022
Q2 | $359K | Buy |
31,456
+22,315
| +244% | +$254K | ﹤0.01% | 2218 |
|
2022
Q1 | $83.3K | Sell |
9,141
-11,258
| -55% | -$103K | ﹤0.01% | 2847 |
|
2021
Q4 | $304K | Buy |
20,399
+4,958
| +32% | +$74K | ﹤0.01% | 2613 |
|
2021
Q3 | $397K | Buy |
15,441
+12,805
| +486% | +$329K | ﹤0.01% | 2260 |
|
2021
Q2 | $68.7K | Sell |
2,636
-4,313
| -62% | -$112K | ﹤0.01% | 2560 |
|
2021
Q1 | $245K | Buy |
6,949
+1,226
| +21% | +$43.3K | ﹤0.01% | 2397 |
|
2020
Q4 | $144K | Sell |
5,723
-6,949
| -55% | -$175K | ﹤0.01% | 2395 |
|
2020
Q3 | $478K | Sell |
12,672
-8,099
| -39% | -$305K | ﹤0.01% | 1667 |
|
2020
Q2 | $889K | Sell |
20,771
-915
| -4% | -$39.2K | ﹤0.01% | 1338 |
|
2020
Q1 | $422K | Buy |
21,686
+16,112
| +289% | +$313K | ﹤0.01% | 1884 |
|
2019
Q4 | $145K | Sell |
5,574
-1,111
| -17% | -$28.9K | ﹤0.01% | 2459 |
|
2019
Q3 | $182K | Buy |
6,685
+3,244
| +94% | +$88.4K | ﹤0.01% | 2187 |
|
2019
Q2 | $92.4K | Buy |
+3,441
| New | +$92.4K | ﹤0.01% | 2472 |
|